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Supraceliac aortorenal bypass 
Ryan T. Hagino,  MD,  R. James Valentine, MD,  and G. Patrick Clagett, MD,  
Dallas, Tex. 
Purpose: To determine the efficacy and durability of supraceliac aortorenal bypass grafting 
for symptomaUc atherosclerotie r nal artery disease. 
Methods: Retrospective r view of a 10-year, single-instituUon experience. 
Results: Seventeen patients underwent 27 bypass procedures (seven tmilateral, 10 bilat- 
eral) for atherosclerotic renovascular hypertension. The patients' mean ag e was 62.7 + 
8.8 years. Diffuse aortoiliac and visceral atherosclerosis was confirmed on arteriogram; 
most (88%) celiac axis branches and all infrarenal aortas nd common iliac arteries were 
found unsuitable for use as a donor vessel. Twenty-six bypass procedures (96%) were 
performed with autologous vein grafts. Seventeen bypass procedures (63%) were per- 
formed during partial aortic occlusion. There were no operative deaths or early occlu- 
sions. Postoperative complicafions occurred in four pafients (24%). The mean duration f 
follow-up was 28 - 19 months (range, 2 to 69 months). By life table analysis, the 5-year 
primary patency and assisted primary patency rates were 95% and 100%, respectively. The 
mean systolic blood pressure decreased from 180 -+ 38 mm Hg to 135 _+ 20 mm Hg (p = 
0.0003), and the mean diastolic blood pressure decreased from 96 + 16 mm Hg to 77 + 
9 mm Hg (p = 0.0002). The number of antihypertensive medications decreased from 
2.8 -+ 1.2 to 1.4 - 1.0 (p = 0.002). Significant improvement in serum creatinine l vel was 
seen among paUents with preoperative r nal instrfficiency. Hypertension was cured in 
29%, improved in 53%, and unchanged in 18%. During late follow-up, only four paUents 
(24%) required subsequent aortic reconstruction. 
Conclusion: Supraceliac aortorenal bypass grafting is a safe and durable alternative for 
renal artery revascularization. This technique should be considered in patients who have 
diffuse infrarenal aortoiliac and visceral artery occlusive disease and reqtfire renal revas- 
cularization procedures. (J Vase Surg 1997;26:482-91.) 
The indications for renal revascularization in pa- 
tients who have atherosclerosis are becoming better 
defined.l-4 However, the diffuse nature ofatheroscle- 
rosis offen renders the aorta and iliac arterics inade- 
quate as inflow sites for renal artery bypass graffing. 
Alternatives include combined aortic and renal artery 
reconstruction or extraanatomic bypass grafting. 
Combined aorfic reconstruction and renal revascu- 
larization procedures can be performed with accept- 
able results in carefully selected patients, 6 but most 
reports have documented additive morbidity and 
mortality rates. 4,7-9 The durability of celiac axis 
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branch vessels as sources of inflow vessels for renal 
bypass grafts is excellent, ~°-12 provided these arteries 
are not affected by flow-limiting lesions. We have 
previously documented that hemodynamically signif- 
icant celiac artery stenoses are prevalent in patients 
with advanced (>75% diameter loss) renal artery 
stenoses, la In those patients with celiac artery steno- 
ses in whom combined aortic and renal revasculariza- 
tion is undesirable, we have favored the use of the 
supraceliac aorta as an inflow source for renal artery 
bypass graffing. As described by Fry and Fry, 14 the 
supraceliac aortorenal bypass procedure seems ideally 
suited in these circumstances, hut its performance 
has heretofore been undocumented. The purpose of  
this study" was to determine the efficacy and the 
durability of the supraceliac aortorenal bypass proce- 
dure in patients with atherosclerotic renal artery dis- 
ease .  
PAT IENTS AND METHODS 
The medical records of patients who underwent 
supraceliäc aortorenal bypass procedures were exam- 
ined to determine demogräphics, atherosclerofic risk 
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factors, surgical indications, operative details, and 
perioperative complications. Supraceliac aortorenal 
grafts combined with antegrade mesenteric grafts 
»vere excluded. Early patency was documented by 
renal angiography or renal duplex scans, and func- 
tional success was determined from the records of 
outpatient clinic visits. Using established criteria for 
functional blood pressure response, 1~ pafients were 
considered cured ifthey were normotensive (diastol- 
ic blood pressure [DBP] <95 mm Hg) on no medi- 
cafion. Therapeutic failures were categorized by an 
insignificant reduction in DBP (reduction -< 20 mm 
Hg) and no change in medication requirements from 
preoperative l vels. All others were considered im- 
proved. Detailed long-term follow-up was estab- 
lished from outpatient records, records of subse- 
quent hospitalizations, and telephone interviews. 
Late patency was documented in most cases by renal 
duplex scans. 
Preoperative arteriograms were reviewed to de- 
termine the degree of renal artery stenosis and to 
determine the status of possible inflow sources. The 
visceral and renal artery branches of the aorta, the 
infrarenal aorta, and the common iliac arteries »vere 
studied in all patients. The degree of stenosis was 
calculated by the following formula: 1 - (narrowest 
diameter of stenosis + diameter of normal segment 
of the main artery). Arteries were categorized ac- 
cording to previously published criteria: (1) normal; 
(2) mild (1% to 49% stenosis); (3) moderate (50% to 
79% stenosis); (4) severe (80% to 99% stenosis); and 
(5) occluded. 13a6 Hemodynamically significant ste- 
nosis was defined as 50% or greater diameter loss. 
Stafisfics. Continuous data are expressed as 
mean _+ standard eviation. Preoperative and late 
follow-up measurements of systolic blood pressure 
(SBP), DBP, serum creatinine level, and number of 
antihypertensive medications were compared using 
Student's paired t test. Long-term patency and long- 
term survival rates were calculated using life table 
analysis. 17 Differences were considered significant if 
the p value was less than 0.05. 
Technique of  supraceliac aortorenal bypass 
grafting. Transperitoneal exposure of the upper ab- 
domen is established through extended, unilateral 
subcostal incision for unilateral renal artery bypass, 
bilateral subcostal "chevron" incision for bilateral 
renal artery reconstruction, or midline incision. 14 Bi- 
lateral subcostal or retroperitoneal flank incisions 
provide xcellent exposure even in obese patients. 
After retracting the left lobe of the liver medially, a 8 
to 10 cm length of supraceliac aorta is exposed i- 
rectly through the gastrohepatic ligament by divid- " 
Fig. 1. Postoperative aortogram dcmonstrates bilateral 
renal artet3, bypass grafts originafing from nondiseased 
supraceliac aorta. 
ing the overlying diaphragmatic crus. Dissection is 
carefully performed close to the aortic wall to avoid 
injuring periaortic lymphatics and surrounding struc- 
tures. The right renal artery is exposed under the 
right renal vein after extended Kocher maneuver. 
Exposure of the left renal artery is performed either 
by medial visceral rotation or through a direct mid- 
line retroperitoneal approach. The patient is anfico- 
agulated with heparin (150 IU/kg). Intravenous 
mannitol (12.5 to 25 g) is given; occasionally, furo- 
semide and renal dose dopamine (l to 3 b~g/kg/ 
min) is given. Using partial or total supraceliac aortic 
vascular control, the proximal anastomosis is created 
in an end-to-side manner. We find that small aortas 
orten require total aorfic control to afford adequate 
exposure during construction of the proximal anas- 
tomosis. Visceral artery control is not mandatory and 
is not roufinely required. Cardiac monitoring during 
supraceliac lamping is conaplimented by careful 
blood pressure control and monitoring with a pul- 
monary artery catheter or transesophageal chocardi- 
ography. Grafts to the right renal artery are conve- 
niently tunneled through the foramen of Winslow, 
anterior to the vena cava. Grafts to the left renal 
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Table I. Major and minor complications 
Patient (yr) Operation Major complication Minor complication Result 
1 (64) Bilateral SAR Respiratory failure 
2 (62) Intraoperative femoral 
thromboembolism 
Postoperative h morrhage 
Bilateral SAR 
3 (70) Right SAR, Left nephrectomy 
4 (64) Right SAR 
5 (39) Right SAR 
ó (8O) Right SAR Myocardial infarction 
Prolonged mechanical 
ventilation 
Femoral thromboembolectomy 
Reexploration 
Plcural effusion Tube thoracostomy 
Pneumothorax Tube thoracostomy 
Pneumothorax Tube thoracostomy 
SAR, Supraceliac ortorenal bypass. 
artery are usually routed behind the body and tail of 
the pancreas. In cases performed without medial vis- 
ceral rotation, left renal artery grafts are passed 
through atunnel easily created by blunt finger dissec- 
tion of the retropancreatic space. The proximal anas- 
tomoses of bilateral renal grafts are created in one of 
two configurations: (1) a pantaloon anastomosis 
where two grafts are sewn together to form a com- 
mon orifice with the aorta12; or (2) sewing one graft 
in an end-to-side manner to the proximal portion of 
the aortorenal graft to the contralateral side. 
RESULTS 
During the past 10 years, 134 patients underwent 
repair of atherosclerotic renal artery stenoses. Forty- 
two patients (31%) underwent extraanatomic renal 
bypass procedures (hepatorenal, splenorenal, or su- 
praceliac aortorenal bypass). A total of 17 patients 
(12.6%) underwent 27 supraceliac aortorenal bypass 
procedures (seven unilateral, 10 bilateral) for symp- 
tomatic renal artery occlusive disease. There »vere 
nine men (53%) and eight women (47%), with a 
mean age of 62.7 + 8.8 years (range, 39 to 80 years). 
Symptomatic coronary disease was evident in 47%. 
All patients were hypertensive. The mean SBP was 
180 + 38 mm Hg, and the mean DBP was 96 + 16 
mm Hg. All patients received antihypertensive med- 
ications. Nine patients (53%) had preoperative evi- 
dence ofimpaired renal function (seru m creatinine -> 
1.3 mg/dl).  Additional atherosclerotic risk factors 
included smoking in 16 patients (94%), diabetes mel- 
litus in three (18%), and hyperlipidemia in five (29%). 
All bypass procedures were performed for suspected 
atherosclerotic renovascular hypertension; no pro- 
phylactic renal artery bypass procedures were per- 
formed for asymptomatic lesions. Seven patients un- 
derwent operations after failed renal percutaneous 
transluminal angioplasty (PTA). Two of these pa- 
tients had undergone multiple PTA procedures be- 
canse ofrecurrent stenoses. 
Preoperative angiograms were available for all 
patients. The angiograms documented severe steno- 
ses (n = 24) or occlusions (n = 3) in all 27 renal 
arteries that were revascularized. Fifteen of 17 pa- 
tients (88%) had celiac arteries that were not usable 
as inflow sources for extraanatomic renal artery revas- 
cularization. Twelve patients had hemodynamically 
significant stenoses in the celiac artcry, and three had 
other anatomic limitations: failed prior splenorenal 
bypass graft (n = 1), prior splenectomy (n = 1), and 
hypoplastic eliac artery (n = 1). None of the 17 
patients had infrarenal aortas or iliac arteries that 
were suitable for inflow. Fourteen had hemodynam- 
ically significant lesions or occlusions (one infrarenal 
aorta had been previously oversewn after removal of 
an infected aortofemoral bypass graft; distal perfu- 
sion was maintained through extraanatomic axil- 
lofemoral bypass graft), two had small (<4 cm) aor- 
tic aneurysms, and one had undergone a previous 
aortofemoral bypass procedure and multiple lower 
abdominal procedures. All normal or mildly diseased 
common iliac arteries that may havc been suitable as 
an inflow source for bypass grafting were excluded 
because of hemodynamically significant infrarenal 
aortic occlusive disease. 
Twenty-six bypass grafts were created using non- 
reversed lower extremity vcins, and one was per- 
formcd using a woven Dacron prosthesis. The major- 
ity (65%) of proximal anastomoses were created 
using partial aortic occlusion. The mean operative 
time was 349 -+ 67 minutes (fange, 273 to 475 
minutes), and the mean intraoperative blood loss was 
979 -+ 663 ml (range, 500 to 2500 ml). Simulta- 
neous nephrectomies of nonfunctioning contralat- 
eral kidneys were performed in three patients. Fig. 1 
is a postoperative angiogram after a bilateral recon- 
struction. 
There were no operative deaths or early graft 
occlusions. Four major morbid events occurred in 
four patients (24%). A myocardial infarction oc- 
curred in an octogenarian with known coronary dis- 
ease after unilateral bypass grafting to a solitary func- 
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Fig. 2. Systolic blood pressure response. Dashed line rep- 
resents mean systolic blood pressure response. 
tioning kidney. Postinfarction bradycardia necessitated 
the placement of a permanent transvenous pace- 
maker. Other complications are detailed in Table I. 
The mean duration of follow-up was 28 + 19 
months (range, 2 to 69 months). Late blood pres- 
sure data and serum creatinine levels were obtained 
from the patients' last known follow-up examination. 
Blood pressure responses are summarized in Figs. 2 
and 3. After operation, the mean SBP decreased from 
180 + 38 mm Hg to 135 + 20 mm Hg (p = 
0.0003). The mean DBP fell from 96 + 16 mm Hg 
to 77 + 9 mm Hg (p = 0.0002). The number of 
antihypertensive m dications decreased from a mean 
of 2.8 + 1.2 to 1.4 -+ 1.0 (p = 0.002). Hypertension 
was cured in five patients (29%), improved in nine 
(53%), and unchanged in three (18%). The mean 
preoperative creatinine values among all 17 patients 
were not statistically different from the postoperative 
values (1.5 + 0.5 mg/dl  compared with 1.3 + 0.5 
mg/dl ;  p = 0.23). However, for the nine patients 
(53%) with impaired preoperative r nal function, the 
mean serum creatinine level decreased from 1.8 + 
0.4 mg/d l  to 1.3 + 0.6 mg/dl  (p = 0.004). All nine 
patients with preoperative renal insufficiency had 
their blood pressure either cured (n = 3) or im- 
proved (n = 6) on late follow-up. 
Long-term graft patency was confirmed by color- 
_ p < 0 .0005 
Preop Postop 
Fig. 3. Diastolic blood pressure response. Dashed line 
represents mean diastolic blood pressure response. 
flow duplex scanning in 22 grafts (81%) and by 
aortography in two grafts. Three grafts were consid- 
ered patent on the basis of clinical criteria alone (a 
graft was considered clinically patent only if the pa- 
tient was cured or improved and had a unilateral 
bypass graft to a solitary functioning kidney without 
evidence of renal insufficiency). One patient had 
gradual recurrent hypertension 12 months after un- 
dergoing a bilateral supraceliac aortorenal bypass 
procedure. Duplex examination detected a high- 
grade anastomofic stenosis at the origin of the left 
bypass graft. Selective arteriography confirmed the 
severity of the lesion (Fig. 4). Vein patch angioplasty 
was used to repair the focal stenosis and assist graft 
patency. Pathologic examination of the lesion was 
consistent with neoinfimal hyperplasia. Thirty-three 
months later, the patient remains normotensive and 
off medication. Overall, the 5-year primary patency 
rate was 0.95 +- 0.15, and the assisted primary pa- 
tency rate was 100% by actuarial life table analysis 
(Fig. 5, Table II). Two late deaths occurred as a 
result of congestive heart failure and stroke at 12 and 
24 months, respectively. Both patients had patent 
grafts confirmed by arteriogram or duplex sonogra- 
phy within a month before death. 
Four patients (24%) eventually required vascular 
surgery for progressive infrarenal aortic disease. Se- 
vere lower extremity ischemia necessitated two sub- 
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Fig. 4. Anteropostefior sclecrive angiogram obtaincd 12 
months after original bypass procedure shows criucal focal 
stenosis at origin of left graft. Pathologic examination of 
lesion revealed intimal hyperplasia. 
sequent aortofemoral bypass procedures and one ax- 
illobifcmoral bypass procedure. One aortoiliac bypass 
graft was placed for a small, asymptomatic aortic 
aneurysm that had increased in sizc. Aortoiliac dis- 
eäse was clinically silcnt or minimally symptomatic 
throughout the follow-up period in the remaining 
paticnts. 
DISCUSSION 
Recent studies have confirmed that the numbcr 
of renal artery bypass procedures performed for ath- 
erosclcrotic renal artery stcnosis is inereasing in par- 
allel with the aging population. 1,4,6,~°,18 Because ath- 
erosclcrotic renal artery disease is orten associated 
with extrarenal occlusive lesions, especially aortoiliac 
occlusive diseasc, surgeons may be faced with inadc- 
quate inflow sources, which has increased the com- 
plexity of surgical repair. L19 Our patients illustrated 
this dilemma. Preoperative arteriograms demon- 
strated severe but ~tsymptomatic or minimally symp- 
tomatic aortic and aortic branch vessel diseasc. With 
the exception of orte patient who had undergone a 
prcvious aortofemoral bypass procedure, no infrare- 
nal aorta or common iliac artery was useable as a 
donor vessel for rcnal artery bypass grafting. Usually, 
an aortic graft would provide excellent inflow for a 
renal artery bypass graft, 1° but that patient had severe 
lower intraabdominal nd retroperitoneal fibrosis 
and adhesions that made dissection treacherous. The 
celiac artery branches were also unusable in 88% of 
patients because of hemodynamically significant oc- 
clusive disease, asymptomatic occlusions, or prior 
branch ligation. Extraanatomic visccral-renal bypass 
grafting was not used in two other patients who had 
mildly diseased ccliac arteries because of the need for 
bilateral reconstruction. In addition to being a rela- 
tive contraindication to celiac branch vessel renal 
bypass graftäng, u wc find supraceliac aortorenal by- 
pass procedures tcchnically easier to pcrform than 
simultaneous hepatorenal and splenorenal bypass 
procedures. 
The utility of the supraceliac aorta as an inflow 
site is based on its tendency to be frec of advanced 
athcrosclerosis. This site has been used successfully in
other types ofrcconstruction. The durability ofante- 
grade aortomesenteric bypass grafts that originate 
from the supraceliac aorta attests to the usefulness of 
this portion of the aorta as a donor site. 2°,21 Trans- 
plant surgeons have found this vesscl an equally use- 
ful location for allograft hepatic artery reimplanta- 
tion. 22 Similarly, Fry and Fry, and others reported 
the potential advantages ofthe supraceliac aorta as an 
inflow site for renal artery bypass grafting.14,23 Access 
can be obtained with minimal ditt]culty and usually 
allows partial aortic occlusion during the proximal 
anastomosis; this may limit visceral ischcmia time and 
ameliorate declamping hypotension. We found this 
maneuver to be possible in the majority of out pa- 
tients. Operative time and blood loss were acceptable 
eren though 60% of our rcconstructions were bilat- 
eral. Minor morbidity in thrce patients could bc 
attributed to the high abdominal aortic dissection 
associated with exposure of the supraceliac aorta (Ta- 
bie I). Inadvertent entry into the pleural space 
through the posterior mediastinum resulted in pneu- 
mothorax or effusion that required tube thoracos- 
tomy in all three. None of these events, however, 
resulted in delayed convalescence or long-term func- 
tional impairment. 
Supraceliac aortorenal bypass grafting can achieve 
results comparable with thosc of isolated aortorenal 
and visceral-renal rtery bypass grafting. The 5-year 
primary patency rate of 95% and assisted primary 
patcncy rate of 100% attests to the durability of this 
procedure. These results are similar to other more 
traditional methods of revascularization, i cluding 
extraanatomic bypass grafting, aortorenal bypass 
grafting, and combined aortic and renal artery recon- 
structions, ,6,1° Hansen et al. 1 reported among 152 
patients who underwent various forms of surgical 
renal revascularization f r atheroocclusive disease, 
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Fig. 5. Life-table graphically depicts primary and assisted primary patency rates. Number of 
grafts at risk are depicted in Table II. 
15% were cured, 75% were improved, and 10% were 
unchanged. This proportion of surgically corrected 
hypertensive patients with atherosclerotic o clusive 
disease of  the renal vessels is consistent throughout 
the literature 4,6,H,12,24 and currently remains a stan- 
dard with which other results can be compared. After 
supraceliac aortorenal bypass grafting in our patients, 
significant reductions in SBP, DBP, and in antihyper- 
tensive medications were observed (Figs. 2 and 3). 
Moreover, with hypertension cured or improved in 
82% of cases, a favorable comparison with conven- 
tional renal revascularization can be made. Mthough 
no significant improvement in serum crcatinine level 
was seen among all patients when considered to- 
gether, the subgroup that had elevated serum creati- 
nine levels did show significant improvement in renal 
function and had a gratifying decrease in postopera- 
tive creafinine values that were maintained on late 
follow-up. 
Another option for correcfing renal artery steno- 
sis is PTA. Although acceptable results may be ob- 
tained in pafients with nonatherosclerofic or athero- 
sclerotic, nonorificial lesions, 2s,26 most pafients with 
diffuse atherosclerosis have osten lesions configuous 
with aorfic plaque. This was the case in our pafients, 
most of  whom had bulky aortic disease. PTA of 
orificial renal artery lesions is not durable, 24,2s,27 and 
seven of our patients had undergone previous fäiled 
renal artery PTA procedures. The supraceliac aorto- 
renal bypass procedure proved surprisingly simple in 
these patients, even in the two who had m ultiplc 
failed attempts at balloon dilation. 
Transaortic renal endarterectomy is an effective 
and durable technique in treating patients with ostial 
renal artery atherosclerosis.l<20 In patients with focal 
central aortic occlusive disease, endarterectomy ay 
be an ideal solution. The procedure allows repair of 
the renal artery without the need for aortic recon- 
struction for asymptomatic disease. Unfortunately, 
in our patients, severe juxtarenal aortic atherosclero- 
sis extended own to the aortic bifurcation or into 
the iliac vessels. We believed the aortic disease was 
too extensive for local renal endarterectomy. Ade- 
quate treatment would have necessitated complete 
infrarenal aortoiliac endarterectomy or aortic re- 
placement in all patients with occlusive disease. 
Simultaneous aortic and renal artery reconstruc- 
tion may also be performed in selected patients with 
diffuse atherosclerosis with favorable outcome. 4 6 
However, combined procedures, although techni- 
cally feasible, are associated with a lower rate of 
improvement of hypertension than renal revascular- 
izafion alone and should be used with discretion, s 7 
Overall morbidity and mortality rates may also be 
increased.4,7 9 As a result, most authors would con- 
tend that simultaneous repair should be undertaken 
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Tab le  I I ,  A.  Pr imary patency  data 
No. withdrawn due to 
No. of grafts No. of failed Loss to 
Interval (mo) at risk grafts Duration follow-up Death 
Interval Cumulative 
patency rate patency (%) SE (%) 
0 to 1 27 0 0 0 
1 to 3 27 0 0 1 
3 to 6 26 0 2 0 
6 to 9 24 0 0 0 
9 to 12 24 0 0 1 
• 12 to 15 23 1 0 2 
15 to 18 19 0 1 0 
18 to 21 18 0 0 1 
21 to 24 17 0 0 2 
24 to 27 13 0 1 0 
27 to 30 12 0 0 0 
30 to 33 12 0 2 0 
33 to 36 10 0 0 0 
36 to 39 10 0 0 0 
39 to 42 10 0 3 0 
42 to 45 7 0 0 0 
45 to 48 7 0 0 0 
48 to 51 7 0 3 0 
51 to 54 4 0 0 0 
54 to 57 4 0 2 0 
57 to 60 2 0 0 0 
0 1.00 100 0.0 
0 1.00 100 0.0 
0 1.00 100 0.0 
0 1.00 100 0.0 
0 1.00 100 0.0 
1 0.95 100 0.0 
0 1.00 95 4.9 
0 1.00 95 5.0 
1 1.00 95 5.2 
0 1.00 95 5.9 
0 1.00 95 6.1 
0 1.00 95 6.1 
0 1.00 95 6.7 
0 1.00 95 6.7 
0 1.00 95 6.7 
0 1.00 95 8.0 
0 1.00 95 8.0 
0 1.00 95 8.0 
0 1.00 95 10.6 
0 1.00 95 10.6 
0 1.00 95 15.0 
Tab le  I I ,  B. Ass isted pr imary  patency  data 
No. withdrawn due to 
No. of grafts No. of failed Loss to 
Interval (mo) at risk grafts Duration follow-up 
Interval Cumulative 
Death patency rate patency (%) SE (%) 
0 to 1 27 0 0 0 
1 to 3 27 0 0 1 
3 to ö 2ö 0 2 0 
ö to 9 24 0 0 0 
9 to 12 24 0 0 1 
12 to 15 23 0 0 2 
15 to 18 20 0 1 0 
18 to 21 19 0 0 1 
21 to 24 18 0 0 2 
24 to 27 14 0 1 0 
27 to 30 13 0 0 0 
30 to 33 13 0 2 0 
33 to 36 11 0 0 0 
36 to 39 11 0 0 0 
39 to 42 11 0 4 0 
42 to 45 7 0 0 0 
45 to 48 7 0 0 0 
48 to 51 7 0 3 0 
51 to 54 4 0 0 0 
54 to 57 4 0 2 0 
57 to 60 2 0 0 0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
1 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
2 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 i00 0.0 
0 1.0 100 0.0 
0 1,0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
0 1.0 100 0.0 
only  in pat ients  whose  symptoms at each site wou ld  
independent ly  warrant  surgical repair, s,19 
Intuit ively,  it seems unreasonab le  to reconst ruct  
the aor to i l iac  system for the  sole purpose  o f  prov id-  
ing inf low for renal artery bypass graft ing.  However ,  
i f  most  o f  these paUents ubsequent ly  requ i red  aorUc 
reconst ruct ion ,  an argument  cou ld  be made for si- 
mu l taneous  repair. But  the  aortoi l iac lesions may 
never  become symptomat ic .  In  one  large contempo-  
rary series, ~ 62% o f  pat ients  who underwent  renal 
artery reconst ruct ion  for atherosc lerot ic  disease dem-  
onst ra ted  signif icant aort ic atheroscleros is  that  was 
cons idered  anatomical ly  severe but  min imal ly  symp-  
tomat ic .  The  authors  found that  none  o f  these pa- 
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tients required subsequent aortic reconstruction. In 
an earlier report, Hansen and colleagues reported on 
47 patients with severe aortoiliac occlusive disease 
who did not undergo aortic replacement during re- 
nN revascularization. Only three eventually required 
an aortofemoral bypass procedure.: In our series, 
despite the angiographic severity of visceral artery, 
renal artery, and aortoiliac occlusive disease, we lim- 
ited repair to the renal artery lesions. With a mean 
follow-up of 28 months and more than one third of 
grafts having follow-up that exceeded 3 years, only 
four patients required additional procedures to cor- 
rect progressive, symptomatic aortoiliac occlusive or 
aneurysmal disease. In spite of the uniform presence 
of severe extrarenal atherosclerosis, the rernainder 
continue to have no compelling indications for aortic 
reconstruction. We find it difficult to predict those 
patients with anatomically severe but asymptomatic 
aortic disease who will eventually require further in- 
tervention. As a result, we continue to adopt a con- 
servative approach to asymptomatic aortic disease. 
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DISCUSSION 
Dr. Richard P. Cambria (Boston, Mass.). Congratu- 
lations to Dr. Hagino on a fine and beautifully illustrated 
presentation and to the group at Southwestern for focus- 
ing our attention on a perhaps underused technique of 
extraanatomic renal artery reconstruction. The authors 
performed this operation in 17 patients over a 10-year 
interval with a low perioperative morbidity rate, admirable 
short- and long-term graft patency rates, and favorable 
function responses to revascularization. Their rationale and 
data reinforce what we and others had emphasized about 
surgical renal artery reconstruction, amely that most fail- 
ures occur early and are technical in nature. Therefore, 
selection ofa particular mode ofreconstruction among the 
various options should be made in accordance with indi- 
vidual patient anatomy. A few years ago at the combined 
vascular meetings, we reported on nearly 300 patients who 
underwent a variety of different renal artery reconstruetion 
procedures for atherosclerotic disease and demonstrated 
that the durability of extraanatomic bypass grafting, which 
in our series was primarily hepatorenal and splenorenal 
reconstructions, was equivalent to aortorenal bypass graft- 
ing. We have not used the procedure described today, but 
we agree that origination of aortorenal bypass grafting 
from a heavily diseased infrarenal aorta is unwise. It has not 
performed weil in our hands. We also agree that combined 
aortic and renal artery reconstruction should generally be 
performed only when independent indications exist for 
correction ofeach. That is, replacement of the aorta for the 
sole purpose of originating an aortorenal bypass graft will 
rarely be required. There are usually better options. How- 
ever, part ofour advocacy ofextraanatomic bypass grafting 
relates to the fact that these are generally "lesser opera- 
tions" than central aortic surgery. The hepatorenal bypass 
procedure can be performed in an hour and a half, with an 
overall operative insult that approximates that of an open 
cholecystectomy. I am not sure this consideration applies 
to the procedure we heard about today. The mean opera- 
tive time in the authors' 17 patients was nearly 6 honrs, 
with an average blood turnover of 1 L. However, there 
were no deaths, and there was minimal morbidity. Further- 
more, origination of a graft from a supraceliac aorta from 
an anterior approach can be ditticult except in very thin 
patients. Four of the anthors patients, or 25%, reqnired 
subsequent treatment of their initially ignored aortic dis- 
ease, and another had a small aneurysm. I suspect we 
would have performed combined aortic and renal artery 
reconstruction i  these patients, because in contemporm T 
practice the mortality rate of that procedure approximates 
that ofisolated aortic surgery. 
I have three questions for the authors. To provide 
perspective on the relative use of this procedure, what was 
the total number of renal artery reconstruction procedures 
performed at your institution over the 10-year interval 
encompassed in your review? Second, what of transaortic 
endarterectomy? It is not mentioned in your manuscript. 
We and others have emphasized the reemergence of this 
operation, which is particularly suited to patients who have 
bilateral proximal renal artery disease, and in my own 
practice it has become the procedure of choice for patients 
who undergo simultaneous bilateral reconstruction for 
atherosclerotic disease. Is this procedure considered in 
your practice? Lastly, the authors emphasized that celiac 
stenosis can preclude use of hepatorenal nd splenorenal 
bypass grafting. They are doubtless aware that the median 
arcuate ligament orten creates a compression on the celiac 
artery that can mimic stenosis. Have you used direct in- 
n'aarterial pressure measurements across the celiac artery to 
either include or exclude it as an appropriate inflow source? 
Dr. Ryan T. Hagino. Thank you, Dr. Cambria. The 
supraceliac aortorenal bypass procedure makes up approx- 
imately 12% to 13% of the procedures performed at our 
institution over the past l 0 years for the surgical treatment 
of atherosclerotic renal artery stenosis. Of the 117 other 
reconstructions, approximately 40% of these were com- 
bined aortic and renal revascularizations. Aortorenal by- 
pass procedures made up 25% ofthat group, and visceral to 
renal bypass procedures, traditional extraanatomic bypass 
procedures that is, made up approximately 25%. We per- 
form thromboendarterectomy for central aortic disease in 
approximately 10% ofour patients; we continue to use this 
technique to treat patients who have appropriate anatomy, 
specifically cëntral aortic occlusive disease. However, we 
find that in patients who have severe infrarenal aortic oc- 
clusive disease, the distal endpoint in the endarterectomy 
orten is not cosmetically appealing and the endarterectomy 
ends up extending down to the aortic bifurcation, which 
necessitates replacement of the infrarenal aorta as weil. As 
for the mean operative time, the bilateral reconstructions 
do take longer. Regarding celiac stenoses, our angiogra- 
phers routinely obtain lateral aortograms when they per- 
form angiography for renal artery stenoses. In this series, all 
of the lateral aortograms revealed what appeared to be 
atheroocclusive disease at the celiac artery. Certainly, pres- 
sure measurements in someone with median arcuate liga- 
ment syndrome before and after division of the ligament 
would be wise. 
Dr. Kimberley Hansen (Winston-Salem, N.C.). We 
were squarely in support of your concept regarding direct 
aortorenal reconstruction over indirect or splanchnorenal 
reconstruction a d have had the opportunity to operate on 
about 500 people over the past 81/2 years and roughly 800 
grafts. In only 2% ofthose have we thought it necessa W to 
use indirect or splanchnorenal reconstruction, but I had a 
question regarding the seven patients, I believe, fi'om your 
abstract that had renal insufficiency. You performed nine 
bilateral procedures and you would guess that perhaps 50% 
or 60% of those patients with abnormal renal function 
before the operation with global renal revascularization 
might be improved, but none were, at least in the abstract. 
Do you think that the addition of a supraceliac cross-clamp 
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even when you attempt to make that a partial occluding 
clamp might add additionally to the renal ischemia nd 
thereby limit the retrieval ofyour renal function? 
Dr. Hagino. Yes, I believe that could be a problem. 
Certainly, asignificant minority (40%) of patients required 
complete supraceliac aortic cross-clamping to reconstruct 
the proximal anastomosis. I am not sure whether this is a 
significant problem. No improvement in renal function 
was seen when examining the entire cohort. However, the 
nine patients with preoperative r nal insufficiency, when 
examined as a separate group, did show significant im- 
provement in renal function in follow-up, In addition, all 
nine patients had hypertension that was either cured (three 
patients) or improved (six patients). 
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